Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Future Positive Capital is a venture capital firm founded in 2016, dedicated to supporting companies that create sustainable futures. The organization operates from various locations, including the USA and Europe, and has a fund size of $57 million. Future Positive Capital focuses on investing in entrepreneurs who tackle global challenges through innovative solutions, emphasizing sustainability and social impact.
Since its inception, Future Positive Capital has built a diverse portfolio of 41 companies, reflecting its commitment to addressing pressing global issues. The firm has established a reputation for investing in transformative ideas across multiple sectors, including biotech, healthcare, climate, energy, and consumer products. Notable milestones include the acquisition of Biobeats by Huma Therapeutics, showcasing the firm's ability to identify and support high-potential companies.
Future Positive Capital invests primarily in the seed and Series A stages, with check sizes ranging from $500,000 to $3 million. The firm targets a variety of sectors, including biotech, healthcare, climate, energy, and consumer products. Their investment strategy emphasizes supporting entrepreneurs who are redesigning systems and rethinking economies to create holistic value. This approach aligns with their mission to address global challenges through innovative solutions.
The firm operates globally, with a particular focus on North America and Europe. Future Positive Capital seeks to partner with companies that are in various stages of development, providing them with the necessary resources and support to scale effectively. The organization values collaboration with startups that share its vision of creating sustainable futures through advanced technologies and impactful solutions.
Future Positive Capital's portfolio includes a diverse range of companies that are making significant strides in their respective fields. Notable portfolio companies include:
This diverse portfolio reflects Future Positive Capital's commitment to investing in companies that address critical global challenges, particularly in the realms of sustainability and health.
Joshua Abram: Co-founder and Co-CEO, with a background in venture capital and a focus on sustainable investments.
Alan Murray: Co-founder and Co-CEO, experienced in supporting innovative startups across various sectors.
Alejandro Chavez-Badiola: Co-founder & CPO, specializing in product development and market strategy.
Victor Sebag: Co-founder & CEO of Ouihelp, with expertise in technology solutions for elderly care.
Pierre-Emmanuel Bercegeay: Co-founder of Ouihelp, focused on enhancing at-home care services.
Bastien Gandouet: Co-founder & CTO of Ouihelp, experienced in technology development for healthcare.
Dainis Kruze: CEO of Aerones, specializing in robotics for renewable energy maintenance.
Janis Putrams: CTO of Aerones, with a background in engineering and technology innovation.
To pitch to Future Positive Capital, founders should visit their website at futurepositivecapital.com. The firm prefers pitches that include a clear overview of the business model, market opportunity, and how the startup's solutions align with their focus on sustainability. Founders should expect a response within a few weeks after submission.
Future Positive Capital has been actively investing in innovative companies, with a total of 41 investments to date. Recent notable investments include Conceivable Life Sciences and Aerones, reflecting the firm's commitment to supporting sustainable solutions in healthcare and renewable energy.
In addition to these investments, Future Positive Capital successfully exited from Biobeats, which was acquired by Huma Therapeutics. This exit highlights the firm's ability to identify and support high-potential companies in the health tech sector.
What are Future Positive Capital's investment criteria?
Future Positive Capital invests in seed and Series A stages, focusing on companies that address global challenges through innovative solutions. They target sectors such as biotech, healthcare, climate, energy, and consumer products.
How can I apply or pitch to Future Positive Capital?
Founders can pitch their ideas through the Future Positive Capital website at futurepositivecapital.com. The firm encourages entrepreneurs to present their innovative solutions that align with their mission of sustainability.
What makes Future Positive Capital different from other venture capital firms?
Future Positive Capital emphasizes a holistic approach to value creation, focusing on sustainable solutions that address pressing global issues. Their commitment to supporting entrepreneurs who are redesigning systems sets them apart.
What is the geographic scope of Future Positive Capital's investments?
The firm invests globally, with a strong presence in North America and Europe. They seek to partner with companies operating in diverse geographies.
What kind of post-investment involvement does Future Positive Capital have?
Future Positive Capital provides strategic guidance, access to a network of industry experts, and support in navigating the complexities of scaling innovative solutions. They are committed to fostering sustainable growth and impact.
What is the typical check size for investments?
Future Positive Capital typically invests between $500,000 and $3 million in their portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.